UnknownPhase 3NCT00864201

A Study to Evaluate the Use of Bosentan in Patients With Exercise Induced Pulmonary Arterial Hypertension Associated With Connective Tissue Disease

Studying Pulmonary arterial hypertension associated with connective tissue disease

Last synced from ClinicalTrials.gov May 19, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Hamilton Health Sciences Corporation
Principal Investigator: Christine Bradley
Hamilton Health Sciences Corporation
Intervention: bosentan(drug)
Enrollment: 10 enrolled
Eligibility: 18 years · All sexes
Timeline: 2009 – 2010

Study locations (1)

Victoria Medical Center, Hamilton, Ontario, Canada

Collaborators

Actelion

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00864201 on ClinicalTrials.gov

← Back to all trials